These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 16781483

  • 1. The diagnosis of polycythemia vera: new tests and old dictums.
    Tefferi A.
    Best Pract Res Clin Haematol; 2006; 19(3):455-69. PubMed ID: 16781483
    [Abstract] [Full Text] [Related]

  • 2. The rise and fall of red cell mass measurement in polycythemia vera.
    Tefferi A.
    Curr Hematol Rep; 2005 May; 4(3):213-7. PubMed ID: 15865874
    [Abstract] [Full Text] [Related]

  • 3. WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.
    Michiels JJ, De Raeve H, Hebeda K, Lam KH, Berneman Z, Schroyens W, Schwarz J.
    Leuk Res; 2007 Aug; 31(8):1031-8. PubMed ID: 17367853
    [Abstract] [Full Text] [Related]

  • 4. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J, Kvasnicka HM, Zankovich R, Diehl V.
    Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
    [Abstract] [Full Text] [Related]

  • 5. Red cell mass and plasma volume measurements in polycythemia: evaluation of performance and practical utility.
    Sirhan S, Fairbanks VF, Tefferi A.
    Cancer; 2005 Jul 01; 104(1):213-5. PubMed ID: 15889449
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
    Mossuz P, Girodon F, Donnard M, Latger-Cannard V, Dobo I, Boiret N, Lecron JC, Binquet C, Barro C, Hermouet S, Praloran V.
    Haematologica; 2004 Oct 01; 89(10):1194-8. PubMed ID: 15477203
    [Abstract] [Full Text] [Related]

  • 7. Elevated serum erythropoietin levels in patients with Budd-Chiari syndrome secondary to polycythemia vera: clinical implications for the role of JAK2 mutation analysis.
    Thurmes PJ, Steensma DP.
    Eur J Haematol; 2006 Jul 01; 77(1):57-60. PubMed ID: 16827884
    [Abstract] [Full Text] [Related]

  • 8. A refined diagnostic algorithm for polycythemia vera that incorporates mutation screening for JAK2(V617F).
    Tefferi A.
    Curr Hematol Malig Rep; 2006 Jun 01; 1(2):81-6. PubMed ID: 20425336
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis and therapy of polycythemia vera.
    Lengfelder E, Merx K, Hehlmann R.
    Semin Thromb Hemost; 2006 Apr 01; 32(3):267-75. PubMed ID: 16673281
    [Abstract] [Full Text] [Related]

  • 10. Influence of the assays of endogenous colony formation and serum erythropoietin on the diagnosis of polycythemia vera and essential thrombocythemia.
    Mossuz P, Groupe d'Etudes Multicentriques des Syndrome MyéloProlifératifs (GEMSMP).
    Semin Thromb Hemost; 2006 Apr 01; 32(3):246-50. PubMed ID: 16673278
    [Abstract] [Full Text] [Related]

  • 11. [A 53-year-old man with headache and concentration difficulties].
    Vik A, Berntsen R, Isaksen V, Haug E, Hansen JB.
    Tidsskr Nor Laegeforen; 2005 Oct 06; 125(19):2647-9. PubMed ID: 16231451
    [Abstract] [Full Text] [Related]

  • 12. An inhibitor of Janus kinase 2 prevents polycythemia in mice.
    Mathur A, Mo JR, Kraus M, O'Hare E, Sinclair P, Young J, Zhao S, Wang Y, Kopinja J, Qu X, Reilly J, Walker D, Xu L, Aleksandrowicz D, Marshall G, Scott ML, Kohl NE, Bachman E.
    Biochem Pharmacol; 2009 Aug 15; 78(4):382-9. PubMed ID: 19413997
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis of polycythemia vera based on bone marrow pathology.
    Thiele JM, Kvasnicka HM.
    Curr Hematol Rep; 2005 May 15; 4(3):218-23. PubMed ID: 15865875
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis.
    Silver RT, Chow W, Orazi A, Arles SP, Goldsmith SJ.
    Blood; 2013 Sep 12; 122(11):1881-6. PubMed ID: 23900239
    [Abstract] [Full Text] [Related]

  • 15. The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology.
    Jakovic L, Gotic M, Gisslinger H, Soldatovic I, Sefer D, Tirnanic M, Lekovic D, Jovanovic MP, Schalling M, Gisslinger B, Beham-Schmid C, Simonitsch-Klupp I, Thiele J.
    Ann Hematol; 2018 Sep 12; 97(9):1581-1590. PubMed ID: 29717365
    [Abstract] [Full Text] [Related]

  • 16. [Polycythemia vera].
    Rain JD.
    Rev Prat; 2005 Oct 15; 55(15):1659-68. PubMed ID: 16334202
    [Abstract] [Full Text] [Related]

  • 17. Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.
    Johansson P, Safai-Kutti S, Lindstedt G, Suurküla M, Kutti J.
    Acta Haematol; 2002 Oct 15; 108(1):1-7. PubMed ID: 12145459
    [Abstract] [Full Text] [Related]

  • 18. Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement.
    Maslah N, Ravdan O, Drevon L, Verger E, Belkhodja C, Chomienne C, Cassinat B, Kiladjian JJ, Giraudier S, Schlageter MH.
    Br J Haematol; 2022 Feb 15; 196(3):676-680. PubMed ID: 34562020
    [Abstract] [Full Text] [Related]

  • 19. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H, Bödör C, Reiniger L, Timár B, Csernus B, Szepesi A, Csomor J, Matolcsy A.
    Orv Hetil; 2006 Nov 12; 147(45):2175-9. PubMed ID: 17402211
    [Abstract] [Full Text] [Related]

  • 20. Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study.
    Remacha AF, Montserrat I, Santamaria A, Oliver A, Barceló MJ, Parellada M.
    Haematologica; 1997 Nov 12; 82(4):406-10. PubMed ID: 9299851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.